Rankings
▼
Calendar
CRMD FY 2019 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena
CRMD
CorMedix Inc.
$518M
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$283,266
-34.1% YoY
Gross Profit
-$89,968
-31.8% margin
Operating Income
-$21M
-7416.3% margin
Net Income
-$16M
-5801.3% margin
EPS (Diluted)
$-0.68
Cash Flow
Operating Cash Flow
-$15M
Free Cash Flow
-$15M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$29M
Total Liabilities
$6M
Stockholders' Equity
-$195M
Cash & Equivalents
$17M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$283,266
$429,797
-34.1%
Gross Profit
-$89,968
$33,011
-372.5%
Operating Income
-$21M
-$27M
+21.8%
Net Income
-$16M
-$27M
+38.8%
← Q4 2018
All Quarters
Q1 2019 →